First published: 08.06.2018

Fusion Prostate Biopsy to Diagnose Prostate Cancer

Fusion prostate biopsy is an innovative ground-breaking method to diagnose prostate cancer. How is it performed? What are its advantages?

Prostate cancer is usually a silent disease without any complaints or symptoms reported by the patient and it can only be diagnosed using a biopsy.

Men having irregular PSA levels (examined by a blood test) there is a need to perform prostate biopsy. The procedure is conducted using an ultrasound that enables to sample a few areas from the prostate, but the ultrasound usually does not discern suspicious findings, which makes this biopsy random and not always accurate.

In addition, such routine biopsies are conducted through the rectum and there is a small risk of 2% to develop infections after the biopsy.

In Kaplan, today, we perform the diagnosis sing an innovative, ground-breaking method, led by Dr. Lindner - Fusion Prostate Biopsy

The diagnosis is conducted using an integration of MRI and ultrasound. This technology allows greater accuracy and a significantly lower complication rate.
Using a designated device integrating the MRI and the ultrasound we can know for sure where the suspicious area is, not blindly like in a regular biopsy, locate the cancer location and diagnose it - with minimal risk of infections. The world reports a low rate, only one tenth of the risk of a regular biopsy.

In Kaplan, we already performed more than 100 fusion biopsies, improved the accuracy in comparison with the routine tests and our infection percentage is null. This is a forefront advanced technology accessible to all patients with a 17 form.